Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mucosal and systemic immune correlates of viral control after SARS-CoV-2 infection challenge in seronegative adults
Helen R. Wagstaffe, Ryan S. Thwaites, Arnold Reynaldi, et al.
Science Immunology (2024) Vol. 9, Iss. 92
Open Access | Times Cited: 25

Showing 25 citing articles:

Human SARS-CoV-2 challenge uncovers local and systemic response dynamics
Rik G.H. Lindeboom, Kaylee B. Worlock, Lisa M. Dratva, et al.
Nature (2024) Vol. 631, Iss. 8019, pp. 189-198
Open Access | Times Cited: 46
Defining the balance between optimal immunity and immunopathology in influenza virus infection
Thi H. O. Nguyen, Louise C. Rowntree, Brendon Y. Chua, et al.
Nature reviews. Immunology (2024) Vol. 24, Iss. 10, pp. 720-735
Closed Access | Times Cited: 10
Regulatory workshop on standardisation of clinical procedures, endpoints and data robustness of human challenge studies – A stakeholder meeting report
Irina Meln, Victor M. Cnossen, Nicoletta Corti, et al.
Biologicals (2025) Vol. 90, pp. 101818-101818
Open Access
Neutralizing antibody responses to three XBB protein vaccines in older adults
Guo‐Jian Yang, Mei Lu, Rui-Rui Chen, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access
Modeling suggests SARS-CoV-2 rebound after nirmatrelvir-ritonavir treatment is driven by target cell preservation coupled with incomplete viral clearance
Tin Phan, Ruy M. Ribeiro, Gregory E. Edelstein, et al.
Journal of Virology (2025)
Open Access
Response to comment about article ‘changes in memory and cognition during the SARS-CoV-2 human challenge study’
Christopher Chiu, Adam Hampshire
EClinicalMedicine (2025) Vol. 81, pp. 103143-103143
Open Access
Decreased levels and function of dendritic cells in blood and airways predict COVID‐19 severity
Björn Österberg, Sara Falck‐Jones, Sindhu Vangeti, et al.
Clinical & Translational Immunology (2025) Vol. 14, Iss. 3
Open Access
Circulating neutralizing antibodies and SARS-CoV-2 variant replication following postvaccination infections
Miguel Garcia-Knight, J. Daniel Kelly, Scott Lu, et al.
JCI Insight (2025) Vol. 10, Iss. 5
Open Access
The role of yes‐associated protein in nasal inflammatory diseases
Bing Zhong, Yu Zhao
Eye & ENT Research (2025)
Open Access
Systemic and Mucosal Immunogenicity of Monovalent XBB.1.5-Adapted COVID-19 mRNA Vaccines in Patients with Inflammatory Bowel Disease
Simon Woelfel, Joel Dütschler, Daniel Junker, et al.
Vaccines (2024) Vol. 12, Iss. 7, pp. 774-774
Open Access | Times Cited: 4
Yin and yang of interferons: lessons from the coronavirus disease 2019 (COVID-19) pandemic
Sara Svensson Akusjärvi, Ivan Zanoni
Current Opinion in Immunology (2024) Vol. 87, pp. 102423-102423
Closed Access | Times Cited: 3
The kinetics of SARS-CoV-2 infection based on a human challenge study
Sarafa A. Iyaniwura, Ruy M. Ribeiro, Carolin Zitzmann, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 46
Open Access | Times Cited: 3
Progress and challenges in the clinical evaluation of immune responses to respiratory mucosal vaccines
Xuanxuan Zhang, Jialu Zhang, Si Chen, et al.
Expert Review of Vaccines (2024) Vol. 23, Iss. 1, pp. 362-370
Open Access | Times Cited: 2
Lack of association between classical HLA genes and asymptomatic SARS-CoV-2 infection
Astrid Marchal, Elizabeth T. Cirulli, Iva Neveux, et al.
Human Genetics and Genomics Advances (2024) Vol. 5, Iss. 3, pp. 100300-100300
Open Access | Times Cited: 2
Randomised controlled trial reveals no benefit to a 3-month delay in COVID-19 mRNA booster vaccine
Wen Shi Lee, Jennifer Audsley, Mai-Chi Trieu, et al.
Journal of Clinical Investigation (2024) Vol. 134, Iss. 17
Open Access | Times Cited: 2
Modeling suggests SARS-CoV-2 rebound after nirmatrelvir-ritonavir treatment is driven by target cell preservation coupled with incomplete viral clearance
Tin Phan, Ruy M. Ribeiro, Gregory E. Edelstein, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Early antiviral CD4+ and CD8+ T cells are associated with upper airway clearance of SARS-CoV-2
Sydney I. Ramirez, Paul Lopez, Farhoud Faraji, et al.
JCI Insight (2024) Vol. 9, Iss. 24
Open Access | Times Cited: 1
The immune markers that predict who can keep SARS-CoV-2 in check

Nature (2024) Vol. 626, Iss. 8000, pp. 695-695
Closed Access
Understanding Antibody Magnitude and Durability Following Vaccination Against Sars-Cov-2
Quiyana M. Murphy, Mohammad M. Sajadi, Stanca M. Ciupe, et al.
(2024)
Closed Access
The effect of circulating neutralizing antibodies on the replication of SARS-CoV-2 variants following post-vaccination infections.
Miguel Garcia-Knight, J. Daniel Kelly, Scott Lu, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Role of IgA1 protease-producing bacteria in SARS-CoV-2 infection and transmission: a hypothesis
Michael W. Russell, Mogens Kilian, Jiří Městecký
mBio (2024) Vol. 15, Iss. 10
Open Access
Understanding antibody magnitude and durability following vaccination against SARS-CoV-2
Quiyana M. Murphy, George K. Lewis, Mohammad M. Sajadi, et al.
Mathematical Biosciences (2024) Vol. 376, pp. 109274-109274
Closed Access
A Perspective on Vaccinology
Helen Y. Chu
The Journal of Infectious Diseases (2024)
Closed Access
Next-Generation SARS-CoV-2 Vaccine Formulations and Alternative Routes of Administration
Tara M Babu, Lisa A. Jackson, Hana M. El Sahly
The Journal of Infectious Diseases (2024)
Open Access
STAR LIGHT Study: XBB.1.5 COVID-19 mRNA Vaccines Boost Systemic but Not Mucosal Immunity Against the SARS-CoV-2 JN.1 Variant in Patients with Chronic Liver Diseases
Simon Woelfel, Daniel Junker, Irina Bergamin, et al.
Vaccines (2024) Vol. 12, Iss. 11, pp. 1241-1241
Open Access
Page 1

Scroll to top